JP2002527388A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002527388A5 JP2002527388A5 JP2000575501A JP2000575501A JP2002527388A5 JP 2002527388 A5 JP2002527388 A5 JP 2002527388A5 JP 2000575501 A JP2000575501 A JP 2000575501A JP 2000575501 A JP2000575501 A JP 2000575501A JP 2002527388 A5 JP2002527388 A5 JP 2002527388A5
- Authority
- JP
- Japan
- Prior art keywords
- molecular weight
- number average
- average molecular
- hpmc
- range
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17249198A | 1998-10-14 | 1998-10-14 | |
| US09/172,491 | 1998-10-14 | ||
| PCT/EP1999/007627 WO2000021525A2 (en) | 1998-10-14 | 1999-10-12 | Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006221194A Division JP4938383B2 (ja) | 1998-10-14 | 2006-08-14 | 徐放性医薬組成物および薬学的活性剤の放出の方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002527388A JP2002527388A (ja) | 2002-08-27 |
| JP2002527388A5 true JP2002527388A5 (enExample) | 2006-10-05 |
Family
ID=22627919
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000575501A Pending JP2002527388A (ja) | 1998-10-14 | 1999-10-12 | 徐放性医薬組成物および薬学的活性剤の放出の方法 |
| JP2006221194A Expired - Fee Related JP4938383B2 (ja) | 1998-10-14 | 2006-08-14 | 徐放性医薬組成物および薬学的活性剤の放出の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006221194A Expired - Fee Related JP4938383B2 (ja) | 1998-10-14 | 2006-08-14 | 徐放性医薬組成物および薬学的活性剤の放出の方法 |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP1121116B1 (enExample) |
| JP (2) | JP2002527388A (enExample) |
| KR (1) | KR100517090B1 (enExample) |
| CN (1) | CN1196481C (enExample) |
| AR (2) | AR020780A1 (enExample) |
| AT (1) | ATE382345T1 (enExample) |
| AU (1) | AU765475B2 (enExample) |
| BR (1) | BR9911648A (enExample) |
| CA (1) | CA2346868C (enExample) |
| CO (1) | CO5140079A1 (enExample) |
| CY (1) | CY1107874T1 (enExample) |
| DE (1) | DE69937891T2 (enExample) |
| DK (1) | DK1121116T3 (enExample) |
| ES (1) | ES2297936T3 (enExample) |
| HK (1) | HK1040920B (enExample) |
| HU (1) | HUP0104268A3 (enExample) |
| ID (1) | ID29350A (enExample) |
| IL (2) | IL142375A0 (enExample) |
| MY (1) | MY121105A (enExample) |
| NO (1) | NO327285B1 (enExample) |
| NZ (1) | NZ511010A (enExample) |
| PE (1) | PE20001110A1 (enExample) |
| PL (1) | PL198850B1 (enExample) |
| PT (1) | PT1121116E (enExample) |
| RU (1) | RU2259826C2 (enExample) |
| SK (2) | SK286595B6 (enExample) |
| TR (1) | TR200101088T2 (enExample) |
| TW (1) | TW577738B (enExample) |
| WO (1) | WO2000021525A2 (enExample) |
| ZA (1) | ZA200103001B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6569461B1 (en) | 1999-03-08 | 2003-05-27 | Merck & Co., Inc. | Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors |
| US6242003B1 (en) * | 2000-04-13 | 2001-06-05 | Novartis Ag | Organic compounds |
| WO2001093859A1 (en) | 2000-06-09 | 2001-12-13 | Lek Pharmaceuticals D.D. | Stable pharmaceutical product and formulation |
| CA2426666A1 (en) * | 2000-09-29 | 2002-04-04 | Solvay Pharmaceuticals B.V. | Ion-strength independent sustained release pharmaceutical formulation |
| US20060127474A1 (en) | 2001-04-11 | 2006-06-15 | Oskar Kalb | Pharmaceutical compositions comprising fluvastatin |
| EP1537880A4 (en) * | 2002-09-11 | 2009-07-01 | Takeda Pharmaceutical | Sustained release preparation |
| CA2520197A1 (en) * | 2003-04-23 | 2004-11-04 | Ferring B.V. | Sachet for a pharmaceutical composition |
| US8987322B2 (en) | 2003-11-04 | 2015-03-24 | Circ Pharma Research And Development Limited | Pharmaceutical formulations for carrier-mediated transport statins and uses thereof |
| DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
| KR100582347B1 (ko) * | 2004-12-30 | 2006-05-22 | 한미약품 주식회사 | 3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법 |
| CA2615941A1 (en) * | 2005-08-05 | 2007-02-15 | Orbus Pharma Inc. | Stabilized extended release pharmeceutical compositions comprising an hmg-coa reductase inhibitor |
| CA2642195A1 (en) * | 2006-02-24 | 2007-09-07 | Teva Pharmaceutical Industries Ltd. | Fluvastatin sodium pharmaceutical compositions |
| RU2342144C1 (ru) * | 2007-04-05 | 2008-12-27 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтический состав, обладающий противосудорожным и психотропным действием |
| RU2356532C2 (ru) * | 2007-06-01 | 2009-05-27 | Открытое Акционерное Общество "Отечественные Лекарства" | Фармацевтическая композиция проксодолола с контролируемым высвобождением |
| CN102805739B (zh) * | 2012-04-10 | 2013-08-14 | 宋芸 | 氟伐他汀钠缓释包衣滴丸及其制备方法 |
| JP2016504391A (ja) * | 2013-01-09 | 2016-02-12 | エッジモント ファーマシューティカルズ リミテッド ライアビリティ カンパニー | ロラゼパムの制御放出製剤 |
| CN106344535B (zh) * | 2016-08-29 | 2019-09-20 | 济南康和医药科技有限公司 | 一种氟伐他汀钠微孔渗透泵控释片及其制备方法 |
| CN118593482A (zh) | 2017-12-05 | 2024-09-06 | 赛诺维信制药公司 | 非外消旋混合物及其用途 |
| KR20200110317A (ko) | 2017-12-05 | 2020-09-23 | 선오비온 파마슈티컬스 인코포레이티드 | 결정형 및 이의 제조 방법 |
| IL281761B2 (en) | 2018-09-25 | 2025-09-01 | Ponce De Leon Health Designated Activity Company | Process for preparing calcium alpha-ketoglutarate |
| AU2020286441A1 (en) | 2019-06-04 | 2022-01-06 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
| BR112021024952A2 (pt) * | 2019-06-10 | 2022-02-15 | Ponce De Leon Health Designated Activity Company | Composições de liberação sustentada de alfa-cetoglutarato |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4915954A (en) * | 1987-09-03 | 1990-04-10 | Alza Corporation | Dosage form for delivering a drug at two different rates |
| EP0465096A1 (en) * | 1990-06-26 | 1992-01-08 | Merck & Co. Inc. | Plasma cholesterol level lowering composition |
| ZA959221B (en) * | 1994-11-02 | 1997-04-30 | Janssen Pharmaceutica Nv | Cisapride extended release |
| NZ286920A (en) * | 1995-07-03 | 1997-06-24 | Sankyo Co | Use of combination of hmg-coa reductase inhibitors and of insulin sensitizers for the prevention/treatment of arteriosclerosis or xanthoma |
| GB9523752D0 (en) * | 1995-11-21 | 1996-01-24 | Pfizer Ltd | Pharmaceutical formulations |
| CZ288545B6 (cs) * | 1995-12-22 | 2001-07-11 | Kowa Company, Ltd. | Stabilizovaná farmaceutická kompozice na bázi kyseliny (E)-3,5-dihydroxy-7-[4´-4´´-fluorfenyl-2´-cyklopropylchinolin-3´-yl]-6-heptenové |
| SE9603667D0 (sv) * | 1996-10-08 | 1996-10-08 | Astra Ab | Pharmaceutical compositions |
-
1999
- 1999-10-05 CO CO99062951A patent/CO5140079A1/es unknown
- 1999-10-12 WO PCT/EP1999/007627 patent/WO2000021525A2/en not_active Ceased
- 1999-10-12 KR KR10-2001-7004708A patent/KR100517090B1/ko not_active Expired - Lifetime
- 1999-10-12 CN CNB998120812A patent/CN1196481C/zh not_active Expired - Lifetime
- 1999-10-12 AR ARP990105146A patent/AR020780A1/es not_active Application Discontinuation
- 1999-10-12 PE PE1999001027A patent/PE20001110A1/es not_active IP Right Cessation
- 1999-10-12 AU AU60909/99A patent/AU765475B2/en not_active Expired
- 1999-10-12 AT AT99947489T patent/ATE382345T1/de active
- 1999-10-12 SK SK509-2001A patent/SK286595B6/sk not_active IP Right Cessation
- 1999-10-12 CA CA002346868A patent/CA2346868C/en not_active Expired - Lifetime
- 1999-10-12 NZ NZ511010A patent/NZ511010A/en not_active IP Right Cessation
- 1999-10-12 JP JP2000575501A patent/JP2002527388A/ja active Pending
- 1999-10-12 DE DE69937891T patent/DE69937891T2/de not_active Expired - Lifetime
- 1999-10-12 SK SK5054-2008A patent/SK286596B6/sk not_active IP Right Cessation
- 1999-10-12 ID IDW20010807A patent/ID29350A/id unknown
- 1999-10-12 BR BR9911648-0A patent/BR9911648A/pt not_active Application Discontinuation
- 1999-10-12 HK HK02102698.9A patent/HK1040920B/zh not_active IP Right Cessation
- 1999-10-12 RU RU2001111882/15A patent/RU2259826C2/ru active
- 1999-10-12 PL PL348109A patent/PL198850B1/pl unknown
- 1999-10-12 HU HU0104268A patent/HUP0104268A3/hu not_active Application Discontinuation
- 1999-10-12 ES ES99947489T patent/ES2297936T3/es not_active Expired - Lifetime
- 1999-10-12 PT PT99947489T patent/PT1121116E/pt unknown
- 1999-10-12 TR TR2001/01088T patent/TR200101088T2/xx unknown
- 1999-10-12 DK DK99947489T patent/DK1121116T3/da active
- 1999-10-12 EP EP99947489A patent/EP1121116B1/en not_active Revoked
- 1999-10-12 IL IL14237599A patent/IL142375A0/xx unknown
- 1999-10-13 MY MYPI99004430A patent/MY121105A/en unknown
- 1999-10-14 TW TW088117692A patent/TW577738B/zh not_active IP Right Cessation
-
2001
- 2001-04-02 IL IL142375A patent/IL142375A/en not_active IP Right Cessation
- 2001-04-04 NO NO20011695A patent/NO327285B1/no not_active IP Right Cessation
- 2001-04-11 ZA ZA200103001A patent/ZA200103001B/en unknown
-
2006
- 2006-08-14 JP JP2006221194A patent/JP4938383B2/ja not_active Expired - Fee Related
-
2008
- 2008-02-04 CY CY20081100134T patent/CY1107874T1/el unknown
- 2008-11-11 AR ARP080104921A patent/AR069281A2/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002527388A5 (enExample) | ||
| TW426528B (en) | Controlled release formulations for poorly soluble drugs | |
| US4756911A (en) | Controlled release formulation | |
| PL187764B1 (pl) | Tabletki farmaceutyczne o kontrolowanym uwalnianiu zawierające nośnik oparty na sieciowanej amylozie i hydroksypropylometylocelulozie oraz zastosowanie hydroksypropylometylocelulozy | |
| EP0465744B1 (en) | Formulations for sustained release dressings and their use | |
| US5000962A (en) | Long acting diltiazem formulation | |
| TR200101088T2 (tr) | Sürekli salınımlı farmasötik kompozisyon ve farmasötik olarak aktif ajanın salınma metodu | |
| IL161587A (en) | Pharmaceutical composition containing 3 - (3 - dimethylamino - 1 - ethyl - 2 - methyl - propyl) phenol and providing delayed release of the active ingredient | |
| CA2191178C (en) | Long-lasting release nifedipine preparation | |
| JP2005508331A (ja) | 糖尿病の処置のための投与製剤 | |
| US4992277A (en) | Immediate release diltiazem formulation | |
| JP2002097132A (ja) | シロスタゾール有核錠 | |
| RU2001111882A (ru) | Фармацевтическая композиция с замедленным высвобождением фармацевтичесКи активного вещества и способ высвобождения фармацевтически активного вещества | |
| ES2363390T3 (es) | Película monocapa de desintegración rápida para la administración bucal de sustancias activas. | |
| US6994871B2 (en) | Once a day antihistamine and decongestant formulation | |
| TW200302748A (en) | Osmotic delivery system | |
| US20160114043A1 (en) | Stabilized Amine-Containing Actives in Oral Film Compositions | |
| TW201031410A (en) | Pharmaceutical compositions with superior product performance and patient compliance | |
| CN101087595A (zh) | 用于缓释药物的片剂 | |
| RU2004118493A (ru) | Фармацевтическая суспензия для перорального применения | |
| CZ291258B6 (cs) | Orální přípravek, obsahující v matrici bobtnatelné ve vodném prostředí alespoň jednu farmaceutickou účinnou látku | |
| CN116059175B (zh) | 一种普瑞巴林胃漂浮缓释片及其制备方法 | |
| CN110505871B (zh) | 用于药物吸收的高负载快速崩解膜 | |
| AU2005313262B2 (en) | Tablets for the sustained release of indapamide and preparation method thereof | |
| JPS63126825A (ja) | 持続放出性ラベタロール錠剤 |